We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Imaging Platform Characterizes Particles Using Raman Spectroscopy

By LabMedica International staff writers
Posted on 06 Nov 2012
New imaging technology combines automated particle imaging with chemical identification of individual particles using Raman spectroscopy. More...
This automated system measures particle size, shape, and chemical identity in a single platform.

Following the completion of an effective early access program, the Morphologi G3-ID particle characterization system has been launched to the global market. The Morphologi G3-ID, developed by Malvern Instruments (Malvern, UK; www.malvern.com), is designed to unravel complicated particle characterization problems where particle size and shape do not provide adequate data. The early access program was designed to enable users to explore specific applications and to allow full optimization of the product features. Major applications for which it is establishing itself to be particularly valuable are in determining component-specific particle properties of mixtures and blends, such as the particle size of drug materials in asthma inhalers and nasal sprays, and, for instance, in the identification of unknown or suspicious particles in injectable or parenteral products.

The Morphologi G3-ID is designed to meet a wide variety of requirements and to enable all users, from particle characterization scientists with some degree of spectroscopy expertise through to experienced spectroscopists, to gain an in-depth understanding of particulate samples. Simple standard operating procedure (SOP) takes the user from integrated sample dispersion for dry powders through to shape, size, and chemical analysis, with automatic selection, targeting and chemical classification of thousands of individual particles. Measurements can be generated on dry powders, membrane filters, and suspensions.

Malvern Instruments is a developer of measuring performance-controlling material characteristics. These include particle shape and size, zeta potential, molecular weight, size, and conformation, rheologic characteristics and chemical identification. Malvern’s measurement systems for scientists, technologists, and engineers are engineered through customer collaboration. Complementary materials characterization systems provide interrelated measurements that reflect the complexities of particulates and disperse systems, macromolecules, and nanomaterials.

Related Links:

Malvern Instruments




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. For bipolar disorder, average time to diagnosis can exceed nine years, and... Read more

Molecular Diagnostics

view channel
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.